Presenilin couples the paired phosphorylation of β-catenin independent of axin: Implications for β-catenin activation in tumorigenesis

Cell

Volumn 110, Issue 6, 2002, Pages 751-762

  Kang, David E ^a   Soriano, Salvador ^a   Xia, Xuefeng ^b   Eberhart, Charles G ^c   De Strooper, Bart ^d   Zheng, Hui ^b   Koo, Edward H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AXIN; BETA CATENIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN D1; PRESENILIN 1; WNT PROTEIN;

ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MEDULLOBLASTOMA; MOUSE; MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; STEADY STATE;

ANIMALIA;

EID: 0037145062     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(02)00970-4     Document Type: Article

References (50)

1. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16:1997;3797-3804.
2. Amit S., Hatzubai A., Birman Y., Andersen J.S., Ben-Shushan E., Mann M., Ben-Neriah Y., Alkalay I. Axin-mediated CKI phosphorylation of β-catenin at Ser 45. a molecular switch for the Wnt pathway Genes Dev. 16:2002;1066-1076.
3. Barth A.I., Pollack A.L., Altschuler Y., Mostov K.E., Nelson W.J. NH2-terminal deletion of β-catenin results in stable colocalization of mutant β-catenin with adenomatous polyposis coli protein and altered MDCK cell adhesion. J. Cell Biol. 136:1997;693-706.
4. Ben Ze'ev A., Shtutman M., Zhurinsky J. The integration of cell adhesion with gene expression. the role of β-catenin Exp. Cell Res. 261:2000;75-82.
5. Bierer L.M., Perl D.P., Haroutunian V., Mohs R.C., Davis K.L. Neurofibrillary tangles, Alzheimer's disease and Lewy bodies. Lancet. 335:1990;163.
6. Cox R.T., McEwen D.G., Myster D.L., Duronio R.J., Loureiro J., Peifer M. A screen for mutations that suppress the phenotype of Drosophila armadillo, the β-catenin homolog. Genetics. 155:2000;1725-1740.
7. Dajani R., Fraser E., Roe S.M., Young N., Good V., Dale T.C., Pearl L.H. Crystal structure of glycogen synthase kinase 3 β structural basis for phosphate-primed substrate specificity and autoinhibition Cell. 105:2001;721-732.
8. De Strooper B., Annaert W. Where Notch and Wnt signaling meet. The Presenilin hub. J. Cell Biol. 152:2001;F17-F20.
9. De Strooper B., Annaert W. Presenilins and the intramembrane proteolysis of proteins. facts and fiction Nat. Cell Biol. 3:2002;E221-E225.
10. Dickinson M.E., Krumlauf R., McMahon A.P. Evidence for a mitogenic effect of Wnt-1 in the developing mammalian central nervous system. Development. 120:1994;1453-1471.
11. Doan A., Thinakaran G., Borchelt D.R., Slunt H.H., Ratovitsky T., Podlisny M., Selkoe D.J., Seeger M., Gandy S.E., Price D.L., Sisodia S.S. Protein topology of Presenilin 1. Neuron. 17:1996;1023-1030.
12. Eberhart C.G., Tihan T., Burger P.C. Nuclear localization and mutation of β-catenin in medulloblastomas. J. Neuropathol. Exp. Neurol. 59:2000;333-337.
13. Fiol C.J., Wang A., Roeske R.W., Roach P.J. Ordered multisite protein phosphorylation. Analysis of glycogen synthase kinase 3 action using model peptide substrates. J. Biol. Chem. 265:1990;6061-6065.
14. Fiol C.J., Williams J.S., Chou C.H., Wang Q.M., Roach P.J., Andrisani O.M. A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression. J. Biol. Chem. 269:1994;32187-32193.
15. Fujiwara H., Hasegawa M., Dohmae N., Kawashima A., Masliah E., Goldberg M.S., Shen J., Takio K., Iwatsubo T. alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4:2002;160-164.
16. Gat U., DasGupta R., Degenstein L., Fuchs E. De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated β-catenin in skin. Cell. 95:1998;605-614.
17. Herreman A., Serneels L., Annaert W., Collen D., Schoonjans L., De Strooper B. Total inactivation of γ-secretase activity in Presenilin-deficient embryonic stem cells. Nat. Cell Biol. 2:2000;461-462.
18. Ikeda S., Kishida S., Yamamoto H., Murai H., Koyama S., Kikuchi A. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J. 17:1998;1371-1384.
19. Ishiguro K., Takamatsu M., Tomizawa K., Omori A., Takahashi M., Arioka M., Uchida T., Imahori K. Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments. J. Biol. Chem. 267:1992;10897-10901.
20. Jicha G.A., Weaver C., Lane E., Vianna C., Kress Y., Rockwood J., Davies P. cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. J. Neurosci. 19:1999;7486-7494.
21. Kang D.E., Soriano S., Frosch M.P., Collins T., Naruse S., Sisodia S.S., Leibowitz G., Levine F., Koo E.H. Presenilin 1 facilitates the constitutive turnover of β-catenin. differential activity of Alzheimer's disease-linked PS1 mutants in the β-catenin-signaling pathway J. Neurosci. 19:1999;4229-4237.
22. Killick R., Pollard C.C., Asuni A.A., Mudher A.K., Richardson J.C., Rupniak H.T., Sheppard P.W., Vardell I.M., Brion J.P., Levey A.I.et al. Presenilin 1 independently regulates β-catenin stability and transcriptional activity. J. Biol. Chem. 276:2001;48554-48561.
23. Kopan R., Goate A. A common enzyme connects Notch signaling and Alzheimer's disease. Genes Dev. 14:2000;2799-2806.
24. Kosik K.S. A partnership that delivers. Nat. Med. 5:1999;149-150.
25. Lardelli M., Williams R., Mitsiadis T., Lendahl U. Expression of the Notch3 intracellular domain in mouse central nervous system progenitor cells is lethal and leads to disturbed neural tube development. Mech. Dev. 59:1996;177-190.
26. Levitan D., Greenwald I. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature. 377:1995;351-354.
27. Li Y.M., Xu M., Lai M.T., Huang Q., Castro J.L., DiMuzio-Mower J., Harrison T., Lellis C., Nadin A., Neduvelil J.G.et al. Photoactivated gamma-secretase inhibitors directed to the active site covalently label Presenilin 1. Nature. 405:2000;689-694.
28. Liu C., Li Y., Semenov M., Han C., Baeg G.H., Tan Y., Zhang Z., Lin X., He X. Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell. 108:2002;837-847.
29. Megason S.G., McMahon A.P. A mitogen gradient of dorsal midline wnts organizes growth in the CNS. Development. 129:2002;2087-2098.
30. Neo S.Y., Zhang Y., Yaw L.P., Li P., Lin S.C. Axin-induced apoptosis depends on the extent of its JNK activation and its ability to down-regulate β-catenin levels. Biochem. Biophys. Res. Commun. 272:2000;144-150.
31. Noll E., Medina M., Hartley D., Zhou J., Perrimon N., Kosik K.S. Presenilin affects arm/β-catenin localization and function in Drosophila. Dev. Biol. 227:2000;450-464.
32. Pai L.M., Orsulic S., Bejsovec A., Peifer M. Negative regulation of Armadillo, a Wingless effector in Drosophila. Development. 124:1997;2255-2266.
33. Peifer M., Polakis P. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science. 287:2000;1606-1609.
34. Polakis P. Wnt signaling and cancer. Genes Dev. 14:2000;1837-1851.
35. Price M.A., Kalderon D. Proteolysis of the Hedgehog signaling effector Cubitus interruptus requires phosphorylation by Glycogen Synthase Kinase 3 and Casein Kinase 1. Cell. 108:2002;823-835.
36. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T.et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 376:1995;775-778.
37. Satoh S., Daigo Y., Furukawa Y., Kato T., Miwa N., Nishiwaki T., Kawasoe T., Ishiguro H., Fujita M., Tokino T.et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat. Genet. 24:2000;245-250.
38. Seeger M., Nordstedt C., Petanceska S., Kovacs D.M., Gouras G.K., Hahne S., Fraser P., Levesque L., Czernik A.J., St. George-Hyslop P.et al. Evidence for phosphorylation and oligomeric assembly of Presenilin 1. Proc. Natl. Acad. Sci. USA. 94:1997;5090-5094.
39. Shen J., Bronson R.T., Chen D.F., Xia W., Selkoe D.J., Tonegawa S. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell. 89:1997;629-639.
40. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K.et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
41. Shibamoto S., Higano K., Takada R., Ito F., Takeichi M., Takada S. Cytoskeletal reorganization by soluble Wnt-3a protein signalling. Genes Cells. 3:1998;659-670.
42. Soriano S., Kang D.E., Fu M., Pestell R., Chevallier N., Zheng H., Koo E.H. Presenilin 1 negatively regulates β-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of β-amyloid precursor protein and Notch processing. J. Cell Biol. 152:2001;785-794.
43. Walter J., Grunberg J., Schindzielorz A., Haass C. Proteolytic fragments of the Alzheimer's disease associated Presenilin-1 and -2 are phosphorylated in vivo by distinct cellular mechanisms. Biochemistry. 37:1998;5961-5967.
44. Wong P.C., Zheng H., Chen H., Becher M.W., Sirinathsinghji D.J., Trumbauer M.E., Chen H.Y., Price D.L., Van der Ploeg L.H., Sisodia S.S. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature. 387:1997;288-292.
45. Xia X., Qian S., Soriano S., Wu Y., Fletcher A.M., Wang X.J., Koo E.H., Wu X., Zheng H. Loss of Presenilin 1 is associated with enhanced β-catenin signaling and skin tumorigenesis. Proc. Natl. Acad. Sci. USA. 98:2001;10863-10868.
46. Yamamoto H., Kishida S., Kishida M., Ikeda S., Takada S., Kikuchi A. Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3β regulates its stability. J. Biol. Chem. 274:1999;10681-10684.
47. Ye Y., Lukinova N., Fortini M.E. Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants. Nature. 398:1999;525-529.
48. Yost C., Torres M., Miller J.R., Huang E., Kimelman D., Moon R.T. The axis-inducing activity, stability, and subcellular distribution of β-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev. 10:1996;1443-1454.
49. Yu G., Chen F., Levesque G., Nishimura M., Zhang D.M., Levesque L., Rogaeva E., Xu D., Liang Y., Duthie M.et al. The Presenilin 1 protein is a component of a high molecular weight intracellular complex that contains β-catenin. J. Biol. Chem. 273:1998;16470-16475.
50. Zhang J., Kang D.E., Xia W., Okochi M., Mori H., Selkoe D.J., Koo E.H. Subcellular distribution and turnover of Presenilins in transfected cells. J. Biol. Chem. 273:1998;12436-12442.